Sökning: WFRF:(Kjeldsen S. E.) >
Angiotensin II rece...
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study
-
Wachtell, K. (författare)
-
Lehto, M. (författare)
-
Gerdts, E. (författare)
-
visa fler...
-
Olsen, M. H. (författare)
-
- Hornestam, Björn, 1957 (författare)
- Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute
-
- Dahlöf, Björn, 1953 (författare)
- Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute
-
Ibsen, H. (författare)
-
Julius, S. (författare)
-
Kjeldsen, S. E. (författare)
-
- Lindholm, Lars H (författare)
- Umeå universitet,Allmänmedicin
-
Nieminen, M. S. (författare)
-
Devereux, R. B. (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2005
- 2005
- Engelska.
-
Ingår i: J Am Coll Cardiol. - : Elsevier BV. - 0735-1097. ; 45:5, s. 712-9
- Relaterad länk:
-
http://www.ncbi.nlm....
-
visa fler...
-
https://doi.org/10.1...
-
https://gup.ub.gu.se...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- OBJECTIVES: This study was designed to evaluate whether different antihypertensive treatment regimens with similar blood pressure reduction have different effects on new-onset atrial fibrillation (AF). BACKGROUND: It is unknown whether angiotensin II receptor blockade is better than beta-blockade in preventing new-onset AF. METHODS: In the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study 9,193 hypertensive patients and patients with electrocardiogram-documented left ventricular hypertrophy were randomized to once-daily losartan- or atenolol-based antihypertensive therapy. Electrocardiograms were Minnesota coded centrally, and 8,851 patients without AF by electrocardiogram or history, who were thus at risk of developing AF, were followed for 4.8 +/- 1.0 years. RESULTS: New-onset AF occurred in 150 patients randomized to losartan versus 221 to atenolol (6.8 vs. 10.1 per 1,000 person-years; relative risk 0.67, 95% confidence interval [CI] 0.55 to 0.83, p < 0.001) despite similar blood pressure reduction. Patients receiving losartan tended to stay in sinus rhythm longer (1,809 +/- 225 vs. 1,709 +/- 254 days from baseline, p = 0.057) than those receiving atenolol. Moreover, patients with new-onset AF had two-, three- and fivefold increased rates, respectively, of cardiovascular events, stroke, and hospitalization for heart failure. There were fewer composite end points (n = 31 vs. 51, hazard ratio = 0.60, 95% CI 0.38 to 0.94, p = 0.03) and strokes (n = 19 vs. 38, hazard ratio = 0.49, 95% CI 0.29 to 0.86, p = 0.01) in patients who developed new-onset AF in the losartan compared to the atenolol treatment arm of the study. Furthermore, Cox regression analysis showed that losartan (21% risk reduction) and new-onset AF both independently predicted stroke even when adjusting for traditional risk factors. CONCLUSIONS: Our novel finding is that new-onset AF and associated stroke were significantly reduced by losartan- compared to atenolol-based antihypertensive treatment with similar blood pressure reduction.
Nyckelord
- Adrenergic beta-Antagonists/*therapeutic use
- Aged
- Aged
- 80 and over
- Angiotensin II Type 1 Receptor Blockers/*therapeutic use
- Atenolol/*therapeutic use
- Atrial Fibrillation/*drug therapy/mortality
- Cause of Death
- Cerebrovascular Accident/*drug therapy/mortality
- Double-Blind Method
- Female
- Humans
- Hypertension/*drug therapy/mortality
- Hypertrophy
- Left Ventricular/*drug therapy/mortality
- Losartan/*therapeutic use
- Male
- Middle Aged
- Prospective Studies
- Recurrence/prevention & control
- Risk Factors
- Survival Rate
- Adrenergic beta-Antagonists/*therapeutic use
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Wachtell, K.
-
Lehto, M.
-
Gerdts, E.
-
Olsen, M. H.
-
Hornestam, Björn ...
-
Dahlöf, Björn, 1 ...
-
visa fler...
-
Ibsen, H.
-
Julius, S.
-
Kjeldsen, S. E.
-
Lindholm, Lars H
-
Nieminen, M. S.
-
Devereux, R. B.
-
visa färre...
- Artiklar i publikationen
-
J Am Coll Cardio ...
- Av lärosätet
-
Göteborgs universitet
-
Umeå universitet